Dupilumab for Eczema: Spotlighting 4-Year Survival Rate Data

This long-term data on dupilumab investigated both survival rates and rationale for treatment discontinuation.

Related Keywords

Seoul , Soult Ukpyolsi , South Korea , Lynn Lew , , Bark Lynn Lew , Kyung Hee University Hospital , Eczema Area , Severity Index , Dupilumab , Eczema , Atopic Dermatitis ,